Biography

Biography

Deep Bio
Commercialization
AI Platform

Deep Bio Strategy &
Communications
AI Platform

Advancing biology to belief—sharper, faster, and leaner.

Next-Generation Oral GLP-1 Receptor Agonist

Investor Relations

Next-Generation Oral GLP-1 Receptor Agonist

Investor Relations

Next-Generation Oral GLP-1 Receptor Agonist

Investor Relations

Biography deploys AutoBio—our proprietary AI platform—for life sciences commercialization to unify science, strategy, and storytelling into a single operating layer. We advance biology to belief—sharper, faster, and leaner—through automated intelligence with expert validation.

Biography's Forward-Deployed Experts (FDEs) ensure end-to-end delivery with mission-critical reliability and regulatory compliance for every deliverable. Clients work directly with FDEs and have full access to the AutoBio platform.

0

+

Life Sciences-Coded Workflows

0

+

Life Sciences-Coded Workflows

0

+

Life Sciences-Coded Workflows

Products

01

01

BioFlow™

BioFlow™

Strategic Workflows

02

02

BioPilot™

BioPilot™

Conversational intelligence

03

03

BioSignal™

BioSignal™

Competitive Intelligence

Features

01

Days Instead of Weeks

Platform automation delivers publication plans, competitive positioning, and congress strategies in 5-7 days—not 4-6 weeks.

02

Regulatory-Grade Reliability

Expert validation eliminates AI errors and ensures every deliverable meets pharmaceutical compliance standards.

03

Complete Source Transparency

Every claim and strategic insight traces to clinical data, regulatory filings, or peer-reviewed sources—providing audit-ready documentation.

04

Life Sciences Intelligence Architecture

Trained on proprietary data and FDA databases, clinical registries, and scientific literature—not generic internet sources—for pharmaceutical-grade intelligence.

Features

01

Days Instead of Weeks

Platform automation delivers publication plans, competitive positioning, and congress strategies in 5-7 days—not 4-6 weeks.

02

Regulatory-Grade Reliability

Expert validation eliminates AI errors and ensures every deliverable meets pharmaceutical compliance standards.

03

Complete Source Transparency

Every claim and strategic insight traces to clinical data, regulatory filings, or peer-reviewed sources—providing audit-ready documentation.

04

Life Sciences Intelligence Architecture

Trained on proprietary data and FDA databases, clinical registries, and scientific literature—not generic internet sources—for pharmaceutical-grade intelligence.

Features

01

Days Instead of Weeks

Platform automation delivers publication plans, competitive positioning, and congress strategies in 5-7 days—not 4-6 weeks.

02

Regulatory-Grade Reliability

Expert validation eliminates AI errors and ensures every deliverable meets pharmaceutical compliance standards.

03

Complete Source Transparency

Every claim and strategic insight traces to clinical data, regulatory filings, or peer-reviewed sources—providing audit-ready documentation.

04

Life Sciences Intelligence Architecture

Trained on proprietary data and FDA databases, clinical registries, and scientific literature—not generic internet sources—for pharmaceutical-grade intelligence.

Biography orchestrates strategic commercialization across five critical domains—from scientific validation to commercial launch.

Forward-Deployed Experts delivering strategic intelligence across five critical domains

Scientific

Pipeline

Product

Medical

Corporate

From Evidence Generation to Market Belief

Scientific

Strategic scientific narratives from clinical evidence and research insights

Pipeline

Asset strategies across development stages—from preclinical to Phase 3

Product

Launch strategies and commercial campaigns from market intelligence

Medical

Publication plans and congress strategies from clinical evidence

Corporate

Corporate strategy and positioning from stakeholder intelligence

8
8
8

%

%

Of Strategic Communications Work, Automated

  • Immunology Biotech

    "Biography delivered our Phase 3 publication plan in 5 days—a process that typically took other firms 6-8 weeks. Their AutoBio platform speed combined with expert validation gave us both the timeline and regulatory confidence medical affairs requires."
  • Early-Stage Biotech

    "Biography's AutoBio platform economics and speed made strategic communications accessible when we actually needed them—Series A timelines don't accommodate 12-week agency cycles."
  • Oncology Biotech

    "The FDE model works. We get platform speed with PhD-level scientific rigor. Their experts catch the nuances AI would miss—mechanism subtleties, competitive context, regulatory landmines. It's the best of both worlds."

Insights

Work With Us

Advance biology to belief—
sharper, faster, and leaner.

Connect with our Biography team to explore AutoBio deployment.

Work With Us

Advance biology to belief—
sharper, faster, and leaner.

Connect with our Biography team to explore AutoBio deployment.

Work With Us

Advance biology to belief—sharper, faster, and leaner.

Connect with our Biography team to explore AutoBio deployment.